Elamipretide
( DrugBank: Elamipretide / KEGG DRUG: Elamipretide, Elamipretide hydrochloride )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 18 | Spinocerebellar degeneration | 1 |
| 21 | Mitochondrial disease | 10 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 324 | Methylglutaconic aciduria | 3 |
18. Spinocerebellar degeneration
Clinical trials : 144 / Drugs : 174 - (DrugBank : 40) / Drug target genes : 50 - Drug target pathways : 75
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
21. Mitochondrial disease
Clinical trials : 108 / Drugs : 107 - (DrugBank : 35) / Drug target genes : 48 - Drug target pathways : 110
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
324. Methylglutaconic aciduria
Clinical trials : 6 / Drugs : 10 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 10
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|